Innovir Biosciences

Hyderabad, India Founded: 2017 • Age: 9 yrs
Offers custom synthesis, analysis, and standards for pharmaceutical and agrochemical sectors.

About Innovir Biosciences

Innovir Biosciences is a Healthcare company based in Hyderabad (India) founded in 2017 by Bodakuntla Lavanya, Prasanna Lakshmi Budaganaboina, and Srinivas Yallamalla. It offers custom synthesis, analysis, and standards for pharmaceutical and agrochemical sectors. It operates on a B2B model. Its Indian entity Innovir Biosciences Private Limited reported revenue of β‚Ή26.7 Lakh. Innovir Biosciences offers products and services including Custom Synthesis, Analysis of Pharmaceutical Compounds, Impurity Standards, Phytochemical Standards, and Novel Molecule Development. Its focus areas include Pharmaceuticals, Drug Development, Custom Synthesis and Agriculture. Similar companies include Sai Life Sciences, NFIL and Sapala Organics; 2 of its 3 listed similar companies have raised funding.

Company details

Innovir Bioscience, established in 2017, is a research-driven company specializing in pharmaceutical, agrochemical, and bulk drug services. It provides custom synthesis, impurity standards, and analysis to support clients like Sun Pharma. Based in Secunderabad, India, the firm focuses on innovation, quality, and regulatory compliance while addressing complex research needs worldwide.

  • Headquarters Hyderabad, India
  • Founders Bodakuntla Lavanya, Prasanna Lakshmi Budaganaboina, Srinivas Yallamalla
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website innovirbio.com
  • Legal Name Innovir Biosciences Private Limited
  • Date of Incorporation 19 Dec, 2017
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹26.7 Lakh

    FY 2025 · +403% YoY

  • Net Loss
    -₹3.4 Lakh

    FY 2025 · -13% margin

  • EBITDA
    -₹57,378

    FY 2025 · -2% margin

Products & Services of Innovir Biosciences

Innovir Biosciences offers a comprehensive portfolio of products and services, including Custom Synthesis, Analysis of Pharmaceutical Compounds, Impurity Standards, Phytochemical Standards, and Novel Molecule Development.

Custom Synthesis
Synthesis Services

Tailored synthesis of fine molecules for pharmaceutical applications.

Analysis of Pharmaceutical Compounds
Analytical Services

Testing and analysis of compounds for drug development needs.

Impurity Standards
Quality Control

Provision of standards to ensure pharmaceutical purity and compliance.

Phytochemical Standards
Natural Products

Standards for phytochemical extraction and analysis in various sectors.

Novel Molecule Development
Research Services

Development of new molecules for pharmaceutical and chemical uses.

Board of directors of Innovir Biosciences Private Limited (Innovir Biosciences)

Innovir Biosciences Private Limited is the primary company behind Innovir Biosciences. The board of Innovir Biosciences Private Limited currently have 3 directors; the longest-serving is Noothy Venkatesham, appointed in 2021. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Noothy Venkatesham
DIN 08682651
Director26 Aug 20215 yrs 2 moInnovir Biosciences Private Limited
Govardhanreddy Kundur
DIN 09295320
Director26 Aug 20215 yrs 2 moInnovir Biosciences Private Limited
Santhoshalaxmi Mahamkali
DIN 10285499
Director23 Feb 20242 yrs 8 moInnovir Biosciences Private Limited

People of Innovir Biosciences

3 people are tracked at Innovir Biosciences (3 in leadership).

NameRoleGroup
Bodakuntla Lavanya
Co-Founder, DirectorLeadership
Prasanna Lakshmi Budaganaboina
Co-Founder, DirectorLeadership
Co-Founder, DirectorLeadership
Premium access

Complete people profiles for Innovir Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Innovir Biosciences

Figures of Innovir Biosciences Private Limited, the primary company behind Innovir Biosciences, for FY 2025. Revenue was ₹26.7 Lakh (+403% year on year). Net loss was -₹3.4 Lakh (-13% margin). EBITDA was -₹57,378 (-2% margin). Revenue has grown at a compounded annual rate of +28% over three years and +18% over five years.

  • ₹26.7 LakhRevenue · FY 2025 · +403% YoY
  • -₹3.4 LakhNet loss · -13% margin
  • -₹57,378EBITDA · -2% margin
  • ₹5 LakhPaid-up capital
  • +28%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Innovir Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Innovir Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Innovir Biosciences

Innovir Biosciences has 3 listed similar companies in our database, 2 of them funded. They include Sai Life Sciences, NFIL and Sapala Organics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sailife.com1999Hyderabad, India$112.18M2,948
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
nfil.in1967Mumbai, India1,476
Fluorinated compounds are synthesized and manufactured customly for various industries.
sapalaorganics.com2005Hyderabad, India$734,962219
Research organization specializing in custom synthesis of various organic compounds
Premium access

Detailed similar companies of Innovir Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Innovir Biosciences

Innovir Biosciences was founded in 2017.

Innovir Biosciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Innovir Biosciences, Innovir Biosciences Private Limited, reported revenue of β‚Ή26.7 Lakh for FY 2025, up 403% year on year.

Innovir Bioscience, established in 2017, is a research-driven company specializing in pharmaceutical, agrochemical, and bulk drug services. It provides custom synthesis, impurity standards, and analysis to support clients like Sun Pharma. Based in Secunderabad, India, the firm focuses on innovation, quality, and regulatory compliance while addressing complex research needs worldwide.

Innovir Biosciences's top competitors include Sai Life Sciences, NFIL and Sapala Organics.

Innovir Biosciences offers Custom Synthesis, Analysis of Pharmaceutical Compounds, Impurity Standards, Phytochemical Standards, and Novel Molecule Development.

Innovir Biosciences operates through Innovir Biosciences Private Limited.

The legal entities of Innovir Biosciences currently have 3 directors, including Santhoshalaxmi Mahamkali, Noothy Venkatesham, Govardhanreddy Kundur.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available